133 related articles for article (PubMed ID: 38239805)
1. Genomic risk prediction of cardiovascular diseases among type 2 diabetes patients in the UK Biobank.
Ye Y; Hu J; Pang F; Cui C; Zhao H
Front Bioinform; 2023; 3():1320748. PubMed ID: 38239805
[No Abstract] [Full Text] [Related]
2. Evaluation of the Performance of the RECODe Equation with the Addition of Polygenic Risk Scores for Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes.
Tsao NL; Judy R; Levin MG; Shakt G; ; ; Voight BF; Chen J; Damrauer SM
medRxiv; 2023 May; ():. PubMed ID: 37205500
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
[TBL] [Abstract][Full Text] [Related]
4. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.
Sun L; Pennells L; Kaptoge S; Nelson CP; Ritchie SC; Abraham G; Arnold M; Bell S; Bolton T; Burgess S; Dudbridge F; Guo Q; Sofianopoulou E; Stevens D; Thompson JR; Butterworth AS; Wood A; Danesh J; Samani NJ; Inouye M; Di Angelantonio E
PLoS Med; 2021 Jan; 18(1):e1003498. PubMed ID: 33444330
[TBL] [Abstract][Full Text] [Related]
5. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.
Tam CHT; Lim CKP; Luk AOY; Ng ACW; Lee HM; Jiang G; Lau ESH; Fan B; Wan R; Kong APS; Tam WH; Ozaki R; Chow EYK; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JKY; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Hu M; Yu W; Tsui SKW; Huang Y; Lan H; Szeto CC; Tang NLS; Ng MCY; So WY; Tomlinson B; Chan JCN; Ma RCW; ;
Genome Med; 2021 Feb; 13(1):29. PubMed ID: 33608049
[TBL] [Abstract][Full Text] [Related]
6. An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes.
Liu W; Zhuang Z; Wang W; Huang T; Liu Z
Front Genet; 2021; 12():632385. PubMed ID: 33643391
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of Type 2 Diabetes and Incident Cardiovascular Disease Risk: UK Biobank and All of Us Cohorts.
Xue Q; Li X; Wang X; Ma H; Heianza Y; Qi L
Mayo Clin Proc; 2023 Aug; 98(8):1192-1204. PubMed ID: 37422735
[TBL] [Abstract][Full Text] [Related]
8. Earlier Age at Type 2 Diabetes Diagnosis Is Associated With Increased Genetic Risk of Cardiovascular Disease.
Lee H; Choi J; Kim NY; Kim JI; Moon MK; Lee S; Park KS; Kwak SH
Diabetes Care; 2023 May; 46(5):1085-1090. PubMed ID: 36939558
[TBL] [Abstract][Full Text] [Related]
9. Polygenic risk scores for cardiovascular diseases and type 2 diabetes.
Wong CK; Makalic E; Dite GS; Whiting L; Murphy NM; Hopper JL; Allman R
PLoS One; 2022; 17(12):e0278764. PubMed ID: 36459520
[TBL] [Abstract][Full Text] [Related]
10. Sleep patterns and risks of incident cardiovascular disease and mortality among people with type 2 diabetes: a prospective study of the UK Biobank.
Hu J; Wang X; Cheng L; Dang K; Ming Z; Tao X; Xu X; Sarker SK; Li Y
Diabetol Metab Syndr; 2024 Jan; 16(1):15. PubMed ID: 38212811
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
[TBL] [Abstract][Full Text] [Related]
12. Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.
Marston NA; Pirruccello JP; Melloni GEM; Koyama S; Kamanu FK; Weng LC; Roselli C; Kamatani Y; Komuro I; Aragam KG; Butterworth AS; Ito K; Lubitz SA; Ellinor PT; Sabatine MS; Ruff CT
JAMA Cardiol; 2023 Feb; 8(2):130-137. PubMed ID: 36576811
[TBL] [Abstract][Full Text] [Related]
13. Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease.
King A; Wu L; Deng HW; Shen H; Wu C
BMC Med; 2022 Nov; 20(1):385. PubMed ID: 36336692
[TBL] [Abstract][Full Text] [Related]
14. Derivation and Validation of Genome-Wide Polygenic Score for Ischemic Heart Failure.
Paranjpe I; Tsao NL; De Freitas JK; Judy R; Chaudhary K; Forrest IS; Jaladanki SK; Paranjpe M; Sharma P; ; ; Glicksberg BS; Narula J; Do R; Damrauer SM; Nadkarni GN
J Am Heart Assoc; 2021 Nov; 10(22):e021916. PubMed ID: 34713709
[TBL] [Abstract][Full Text] [Related]
15. Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study.
Schoepf IC; Thorball CW; Kovari H; Ledergerber B; Buechel RR; Calmy A; Weber R; Kaufmann PA; Nkoulou R; Schwenke JM; Braun DL; Fellay J; Tarr PE;
Clin Infect Dis; 2023 Jan; 76(1):48-56. PubMed ID: 36097729
[TBL] [Abstract][Full Text] [Related]
16. An elevated urinary albumin-to-creatinine ratio increases the risk of incident cardia-cerebrovascular disease in individuals with type 2 diabetes.
Tao J; Sang D; Zhang X; Liu X; Wang G; Chen S; Wu S; Geng W
Diabetol Metab Syndr; 2024 Jan; 16(1):30. PubMed ID: 38291519
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk score validation using Korean genomes of 265 early-onset acute myocardial infarction patients and 636 healthy controls.
Bhak Y; Jeon Y; Jeon S; Yoon C; Kim M; Blazyte A; Kim Y; Kang Y; Kim C; Lee SY; Bae JW; Kim W; Kim YJ; Shim J; Kim N; Chun S; Kim BC; Kim BC; Lee S; Bhak J; Shin ES
PLoS One; 2021; 16(2):e0246538. PubMed ID: 33539413
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis.
Manikpurage HD; Paulin A; Girard A; Eslami A; Mathieu P; Thériault S; Arsenault BJ
Circ Genom Precis Med; 2023 Oct; 16(5):470-477. PubMed ID: 37753708
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease.
Groenland EH; Heidemann BE; van der Laan SW; van Setten J; Koopal C; Bots ML; Asselbergs FW; Visseren FLJ; Spiering W;
Atherosclerosis; 2022 Jun; 350():102-108. PubMed ID: 35317921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
